Neurocrine Biosciences Issues Quarterly Earnings Results, Misses Expectations By 0.23 EPS
| ETNHX Fund | USD 35.88 0.06 0.17% |
Slightly above 62% of Eventide Healthcare's investor base is looking to short. The analysis of overall sentiment of trading Eventide Healthcare Life mutual fund suggests that many investors are alarmed at this time. Eventide Healthcare's investing sentiment can be driven by a variety of factors including economic data, Eventide Healthcare's earnings reports, geopolitical events, and overall market trends.
Eventide |
Neurocrine Biosciences announced its earnings results on Wednesday. The company reported 1.24 earnings per share for the quarter, missing analysts consensus estimates of 1.47 by , reports. Neurocrine Biosciences had a return on equity of 15.68 percent and a net margin of 17.21. The company had revenue of 622.10 million
Read at thelincolnianonline.com
 |
Eventide Healthcare Fundamental Analysis
We analyze Eventide Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eventide Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eventide Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Equity Positions Weight
Equity Positions Weight Comparative Analysis
Eventide Healthcare is currently under evaluation in equity positions weight among similar funds. Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
Eventide Healthcare Life Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eventide Healthcare mutual fund to make a market-neutral strategy. Peer analysis of Eventide Healthcare could also be used in its relative valuation, which is a method of valuing Eventide Healthcare by comparing valuation metrics with similar companies.
Peers
Eventide Healthcare Related Equities
| BFOCX | Berkshire Focus | 1.35 | ||||
| CPOAX | Morgan Stanley | 1.00 | ||||
| ETILX | Eventide Gilead | 0.27 | ||||
| ETGLX | Eventide Gilead | 0.26 | ||||
| ETIHX | Eventide Healthcare | 0.16 |
Other Information on Investing in Eventide Mutual Fund
Eventide Healthcare financial ratios help investors to determine whether Eventide Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eventide with respect to the benefits of owning Eventide Healthcare security.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |